Dr Peter Marks, who has been director of the FDA's Centre for Biologics Evaluation and Research (CBER) since 2016. The abrupt departure of Peter Marks as the director of the FDA's Centre for Biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback